Dr. Shadman is a medical oncologist who specializes in treating patients with blood disorders using novel agents, immunotherapy approaches and stem cell transplant.
Every patient deserves highest quality of care which includes access to novel treatment options. As an academic physician, I have the opportunity of offering a variety of experimental and standard treatments to my patients and I help them make the best choice for their unique condition.
Lymphomas including CLL/SLL and hairy cell leukemia
- Assistant Professor, Medical Oncology Division, University of Washington School of Medicine
- Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- MD: Tehran University of Medical Sciences
- MPH: University of Washington School of Public Health
- Residency: Cleveland Clinic Foundation
- Fellowship: University of Washington Hematology-Oncology
Mazyar Shadman, MD, MPH finds the field of medicine unique. “As a doctor, you need to be able to integrate the art of human interaction with science in a practical fashion,” he says. “To see the patients benefiting from the scientific advances and to be somehow involved in this process is extremely rewarding.”
Dr. Shadman enjoys working with cancer patients. “Their positive attitude and their willingness to fight have always inspired me,” he says.
It is an exciting time for cancer care and research to Dr. Shadman. “We now have access to variety of novel agents that enable us to target cancer cells more specifically without causing major side effects. I am involved in clinical trials using these agents as the only treatment or in combination with more conventional treatments like chemotherapy for treatment of blood cancers. I also study the clinical outcomes of patients who have already been treated. My goal is to identify specific patient- or disease-specific characteristics that can help us understand the behavior of disease and predict its responsiveness to different treatments.”
Finding a “cure” is the universal goal of all scientists and clinicians, Dr. Shadman says. In the meantime and with the help of the novel agents and treatment approaches, he hopes they can make cancer a chronic disease and help patients maintain their desired quality of life while receiving treatment.
Outside of work, Dr. Shadman enjoys spending time with his family and friends, traveling, and learning more about photography.